191 results found for "checkpoint inhibitor"
-
faq
Which IFC is used for the Advanta IO Gene Expression Assay?
We offer configurations of the Advanta™ IO Gene Expression Assay that support the 96.96 and 24.192 Dynamic Array™ IFCs for Gene Expression (GE 96.96 and GE 24.192 IFCs). …
-
faq
What is the Advanta IO Gene Expression Assay?
The Advanta™ IO Gene Expression Assay qPCR assay panel enables profiling of tumor immunobiology and identification of new biomarkers. …
-
faq
Do I have to purchase both panels of the Advanta IO Gene Expression Assay?
No, we offer configurations of the Advanta™ IO Gene Expression Assay that support either panel separately or both panels as a set. …
-
faq
I already have IFCs. Can I just buy the assays for the Advanta IO Gene Expression Assay?
No, the reagents included in the Advanta™ IO Gene Expression Assay have been analytically validated together to ensure optimal performance across all genes. …
-
faq
Is preamplification required in the Advanta IO Gene Expression Assay?
Yes, preamplification is required to achieve the performance characteristics of the assay. …
-
faq
What is the Advanta IO Gene Expression Control 1 and how is it used?
The Advanta™ IO Gene Expression Control 1 (PN 101-7676) is a synthetic control designed to qualitatively ensure that all assays are working. …
-
faq
How many genes are in the Advanta IO Gene Expression Assay?
170 genes are assigned to two sets, designated as Panel A and Panel B. …
-
faq
What genes are covered by the Advanta IO Gene Expression Assay?
The complete panel set includes genes for identification and functional analysis of immune and cancer cells. …
-
article
On Phenotype and Function
Deeply profile T cell checkpoint response with mass cytometry immuno-oncology panels …
-
Software
GO Immuno-Oncology Workbench
GO Immuno-Oncology Workbench is designed to further analyze primary data obtained with the Advanta™ IO Gene Expression Assay. GO Immuno-Oncology Workbench enables users to analyze large cohorts, discover population-level trends and accelerate checkpoint inhibitor research. It is designed by GenomOncology, a leader in the field of cancer molecular pathology analysis. Each license supports one year of use from the date of activation and may be ordered through your Fluidigm account representative. …
-
article
Webinar | Towards an assay of global immune competence
Holden Maecker discusses the need to develop a global assay of immunocompetence …
-
general
GO Immuno-Oncology Workbench
Enable your translational and clinical research in immune oncology …
-
Society for Immunotherapy of Cancer
SITC 2016 …
-
article
Unraveling the Biology of Cancer
Bernd Bodenmiller on revealing new insights into tumors with Imaging Mass Cytometry …
-
event
SITC 2017
SITC 2017 …
-
Publications
Mass Cytometry Bibliography
Publications featuring mass cytometry technology
-
brochure
-
brochure
-
event
AACR 2018
Visualize a new path forward …
-
event
EACR25
Congress of the European Association for Cancer Research …